Previous Article | Next Article ![]()
Mol Cell Biol, March 1998, p. 1312-1321, Vol. 18, No. 3
Genetics Unit, Shriners Hospital, and
Departments of Surgery and Human Genetics, McGill University,
Montréal, Québec H3G 1A6, Canada
Received 10 June 1997/Returned for modification 15 August
1997/Accepted 24 November 1997
The alpha chain of the nascent polypeptide-associated complex
(
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bone-Specific Expression of the Alpha Chain of the
Nascent Polypeptide-Associated Complex, a Coactivator Potentiating
c-Jun-Mediated Transcription


-NAC) coactivator was shown to potentiate the activity of the
homodimeric c-Jun activator, while transcription mediated by the
c-Fos/c-Jun heterodimer was unaffected. The use of deletion mutants in
pull-down assays revealed that
-NAC interacted with amino acids 1 to
89 of the c-Jun protein and that the coactivator could interact with
both the unphosphorylated and the serine 73-phosphorylated form of
c-Jun. N-terminal-deleted c-Jun protein failed to interact with
-NAC
in mammalian two-hybrid assays, while mutant c-Jun proteins lacking the
leucine zipper or the basic domain retained interaction with
-NAC in
vivo. Kinetics studies with purified c-Jun homodimer and recombinant
-NAC proteins allowed determination of the mechanism of coactivation
by
-NAC: the coactivator stabilized the AP-1 complex formed by the
c-Jun homodimer on its DNA recognition sequence through an eightfold
reduction in the dissociation constant (kd) of
the complex. This effect of
-NAC was specific, because
-NAC could
not stabilize the interactions of JunB or Sp1 with their cognate
binding sites. Interestingly, the expression of
-NAC was first
detected at 14.5 to 15 days postconception, concomitantly with the
onset of ossification during embryogenesis. The
-NAC protein was
specifically expressed in differentiated osteoblasts at the centers of
ossification. Thus, the
-NAC gene product exhibits the properties of
a developmentally regulated, bone-specific transcriptional coactivator.
*
Corresponding author. Mailing address: Genetics Unit,
Shriners Hospital, 1529 Cedar Ave., Montréal, Québec H3G
1A6, Canada. Phone: (514) 842-5964. Fax: (514) 842-5581. E-mail:
rst-arnaud{at}shriners.mcgill.ca.
Present address: Laboratoire de génétique
moléculaire, Institut de Recherches Cliniques de Montréal,
Montréal, Québec H2W 1R7, Canada.
Present address: Centre de cancérologie Charles Bruneau,
Hôpital Ste-Justine, Montréal, Québec H3T 1C5,
Canada.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|